Nuffield Division of Clinical Laboratory Sciences
AML-348 A Phase Ib/II Study of Ivosidenib With Venetoclax +/- Azacitidine in IDH1-Mutated Hematologic Malignancies
Lachowiez C. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22, S240 - S241
AML-399 A Phase 2, Open-Label, Multiarm, Multicenter Study to Evaluate Magrolimab Combined With Antileukemia Therapies for First-Line, Relapsed/Refractory, or Maintenance Treatment of Acute Myeloid Leukemia (AML)
Vyas P. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22
Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: A systematic review of randomised controlled trials
Miller LJ. et al, (2022), Clinical Nutrition, 41, 2135 - 2146
A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus
Siddiqi KZ. et al, (2022), Journal of Autoimmunity, 132
The Latest News
26 September 2022
Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.
22 July 2022
The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.